Aim. To study anticancer activity of a series of new thiopyrano [2,3-d]thiazoles with a norbornane fragment in the molecules. The search for trypanocidal properties of target compounds. Methods. Organic synthesis, analytical and spectral methods, pharmacological screening, COMPARE and SAR analysis. Results. Fused thiopyrano [2,3-d]thiazoles bearing the norbornane moiety were synthesized and modified at the C9 and N5 positions of the main core in order to obtain the compounds with a satisfactory pharmacological profile. A number of compounds with significant level of cancer cells growth inhibition were identified; they include a hit-compound N1-(4-chlorophenyl)-2-{2-[6-oxo-5,9-dithia-7-azatetracyclo [9.2. 
Introduction
Thiopyranothiazole core is a good scaffold for design of new pharmacologically interesting molecules [1] [2] [3] [4] [5] [6] . The most efficient method for their synthesis is based on hetero-DielsAlder reaction of 5-ene-4-thioxo-2-thiazolidinones (5-eneisorhodanines). Thus, thiopyranoBioorganic Chemistry ISSN 1993-6842 (on- thiazoles are the derivatives of widely investigated 4-thiazolidinones. There are a number of drug candidates and approved drugs based on 4-thiazolidinone core, such as hypoglycemic glytazones -PPARsγ agonistsRosiglitazone, Pioglitazone (2,4-thiazolidinone derivatives) [7] and aldose reductase inhibitor -Epalrestat (rhodanine derivative) [8] ; anti-inflammatory dual inhibitor of COX-2/5-LOX -Darbufelon (2-aminothiazolidinone derivative) [9] ; diuretic Etozoline (2-ylidene-4-thiazolidinone derivative) [10] ; anticonvulsant Ralitoline (2-ylidene-4-thiazolidinone derivative) etc. [11] . Despite this, modern medicinal chemistry is still interested in the 4-thiazolidinone derivatives as a source of new drugs and a lot of research have been done in this area [12, 13] . Though, there are also comments of some scientists claiming the 4-thiazolidinones, namely 5-ene-4-thiazolidinones (one of the most powerful subtypes of mentioned heterocycles), as pan assay interference compounds (PAINS) due to their possible Michael acceptor functionality, wide spectrum of biological activities and low selectivity [14, 15] . The issues of PAINS remain controversial [12, 13] . Thiopyranothiazoles are hypothesized as biomimetics of the pharmacologically active 5-ene-4-thiazolidinones (synthetic precursors of thiopyranothiazoles) without mentioned Michael acceptor functionality [1, 2, 6] . Taking into account the results of biological activities study of thiopyranothiazoles one can conclude that these compounds might have good pharmacological profile but reveal different chemical and physical properties. The pharmacological activities associated with thiopyranothiazole core are antitumor [1, 2, 5, 6, 16, 17] , antitrypanosomal [18] [19] [20] , antioxidant and anti-inflammatory [21] etc. Moreover, our previous findings showed that introduction of norbornane fragment in thiopyranothiazole molecules contributed to their antitumor activi ty with selectivity towards lung, renal, breast, leukemia and melanoma cancer types [1, 2] . A search for new anticancer agents among thiopyranothiazoles seems to be promising, and the target compounds of this work are shown in Fig. 1 . A number of hypotheses has been put forward in order to explain possible modes of antitumor action of the thiazolidinone derivatives and speculatively thiopyranothiazoles. For example, a mitochondria-depended proapoptic mode of action related with G 0 /G 1 arrest and an activation of ROS production; the caspase-depended and Bcl-depended pathways are the most discussed [13, 22] .
The present work is an extension of our ongoing efforts towards a search for new thiazolidinone-based anticancer agents. Another objective of the study was to discover whether there is any correlation between anticancer and antitrypanosomal activity as the latter was shown for a series of related thiopyranothiazoles [20] . A repurposing approach is one of the currently used methods to discover new active antitrypanosomal agents [18, 23] . For example, anticancer drug Bortezomid showed excellent results in in vitro test against Trypanosome brucei inhibiting the parasites growth at nanomolar concentrations [24] . The DNA topoisomerase inhibitors (aclarubicin, doxorubicin and mitoxantrone) were also tested against bloodstream forms of Trypanosoma brucei and their trypanocidal activities were comparable with those of commercial antitrypanosomal drugs [25] .
Here we addressed the screening of anticancer and antitrypanosomal effects in vitro of new thiopyrano [2,3-d] thiazoles with norbornane core and their N-3 derivatives.
Materials and Methods

Chemistry
All chemicals were of the analytical grade and commercially available. All reagents and solvents were used without further purification and drying. The starting 5-eneisorhodanines (I) [1] and 2,4-thiazolidinedione-5-acetic acid [26] were synthesized as described previously. NMR spectra were determined with Varian Mercury 400 (400 MHz) spectrometer, in DMSO-d 6 using tetramethylsilane as an internal standard. Elemental analyses (C, H, N) were performed on a Perkin-Elmer 2400 CHN analyzer and were within ± 0.4% from the theoretical values. Mass spectra were obtained using electrospray ionization (ESI) techniques on an Agilent 1100 Series LCMS. The purity of the compounds was checked by thin-layer chromatography performed with Merck Silica Gel 60 F254 aluminum sheets.
General procedure for the synthesis of 9-aryl(heteryl)-3,7-dithia-5-azatetracyclo[9.2.1.0 2,10 .0 4, 8 
]tetradecen-4(8)-ones-6 (II).
A mixture of 5-ene-4-thioxo-2-thiazolidinone I (5 mmol), 2-norbornene (6 mmol), catalytic amounts of hydroquinone and acetic acid (15 mL) was heated under reflux during 1 hour and then cooled. Obtained solid products were filtered off, dried and recrystallized from the mixture of DMF/EtOH (1:2) or acetic acid. The mixture of appropriate compound II (3 mmol), pottasium hydroxide (3 mmol), appropriate N-substituted chloroacetamide or ethylchloroacetate (3.3 mmol) and catalytic amounts of KI in the medium of methanol / DMF (2:1) was heated under reflux for 3 hours and cooled. Formed precipitate was filtered and recrystallized from buthanol, acetic acid or mixture of DMF/methanol (1:1). 
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Pharmacology
Anticancer activity screening. In vitro cell line screening of anticancer activity of the synthesized compounds was carried out at the National Cancer Institute within Developmental Therapeutic Program (www.dtp.nci.nih.gov). Anticancer assays were performed according to the US NCI protocol, which was described elsewhere [27] [28] [29] .
Antitrypanosomal activity screening. Bloodstream forms of Trypanosoma brucei brucei (Tbb) strain 90-13 were cultured in HMI9 medium supplemented with 10 % FCS at 37 °C in an atmosphere of 5 % CO 2 [30] . In all experiments, log-phase cell cultures were harvested by centrifugation at 3000×g and immediately used. Drug assays were based on the conversion of a redox-sensitive dye (resazurin) to a fluorescent product by viable cells [31] . Drug stock solutions were prepared in DMSO. Tbb bloodstream forms (10 5 cells/ mL) were cultured in 96-well plates either in the absence or in the presence of different concentrations of inhibitors in a final volume of 200 ml. After the 72 h incubation, resazurin solution was added in each well at the final concentration of 45 mM and fluorescence was measured at 530 nm and 590 nm absorbance after further 4 h incubation. The percentage of inhibition of parasite growth rate was calculated by comparing the fluorescence of parasites maintained in the presence of drug to that in the absence of drug. DMSO was used as a control. Concentration inhibiting 50% of parasite growth (IC 50 ) value was given as the mean +/-the standard deviation of three independent experiments.
Results and Discussion
Chemistry
An approach to the target compounds synthesis was based on the developed protocol utili zing 5-eneisorhodanines as heterodienes and norbornene as dienophile in the hetero-Diels-Alder reaction following our previous fin dings [1, 2] . This approach was proved to be an efficient regio-and stereoselective tool for the functionalized thiazolothiopyrane core formation [4, 32] . One of the promising directions of thiazolothiopyrane optimization is modification of the C5-fragment of the starting 5-eneisorhodanines [5] . For this purpose different 5-eneisorhodanines with bulky benzylidene fragment and heterocyclic fragments at C5 position, including substances bearing substituted phenolic OH group [33, 34] logically active analogues [26, 35] . One more argument in favor of this approach is a decreased toxicity of the N-substituted structurally related 4-thiazolidinones [36] . This goal was achieved via the alkylation reaction and further modification of the exocyclic functional groups. Synthetic protocol included in situ 9-aryl(heteryl) The purity and structure of synthesized compounds were confirmed by the analytical and spectral data. 1 H NMR spectra of the synthesized compounds showed classic system of doublets, triplets and multiplets at δ 1.10-3.30 ppm characteristic for norbornane fragment. A signal of the CH-group's proton linked to the aromatic ring shows doublet at δ 3.36-3.98 ppm and is often overlapped with the norbornane proton signals. In the most cases, signal of the N-CH 2 -CO group corresponds to two doublets of the diastereotopic methylene protons with the spin-spin coupling constant ~16.0 Hz that is caused by the diastereotopici ty of the protons of methylene group. The AMX-system in the form of 3 doublets of doublets is characteristic for CH 2 -CH group (compounds IIIp and IIi).
Anticancer activity
Compounds IIb, IIh, IIIh were selected for primary screening on three tumor cell lines: NCI-H460 (Lung cancer), MCF7 (Breast cancer), SF-268 (CNS cancer) at 10 -4 M concentration. These compounds did not show significant growth inhibition of mentioned cancer cell lines. Moreover, the derivative with thiophene ring in the molecule even increased tumor cell growth (data not shown).
The compounds IIc, IIe, IIIn and IIIu were evaluated at one dose assay towards approximately 60 cell lines (concentration 10 -5 M). The human tumor cell lines represent all forms of cancer (such as, non-small cell lung cancer, colon cancer, breast cancer, ovarian cancer, leukemia, renal cancer, melanoma, prostate cancer). In the screening protocol, each cell line was inoculated and pre-incubated for 24-48 h on a microtiter plate. Test agents were then added at a single concentration and the culture was incubated for further 48 h. The end point determinations were made with a protein binding dye, sulforhodamine B. The results for each test agent were reported as the percent growth (GP) of the treated cells compared to the untreated control cells. The screening results are shown in Table 1 .
All the tested compounds showed rather good growth inhibition levels against Leukemia cell lines. The best growth inhibition results against Leukemia panel were observed for IIe: cell lines CCRF-CEM (GI = 8.12 %) and HL-60(TB) (GI = -44.16 %) and for IIc cell lines CCRF-CEM (GI = 7.01 %). These data cohere with our previously findings about leukemia selective action of the related thiazolidinones [13] . The latter compound also inhibited Non-small cell lung cancer line NCI-H522 (GI = 8.12 %). Compound IIIn inhibited growth of Leukemia cell lines and showed cytostatic effect on HCT-15 line of Colon cancer (GI = -100 %). Complication of the basic core with triazole cycle did not influence the activity level, so IIIu showed only moderate anti-tumor activity with the best GI against renal cancer cell line UO-31 (GI = 29.35 %).
Finally, the compounds IIIn and IIIu were selected for an advanced assay against a pa nel of approximately sixty tumor cell lines at 10-fold dilutions of five concentrations (0.01-100 mM). Additionally, compounds IIa, IId, IIId, IIIg, were involved into the study without prescreening. The percentage of growth was evaluated spectrophotometrically versus controls not treated with test agents after 48-h exposure and using SRB protein assay to estimate cell viability or growth. The dose-response parameters were calculated for each cell line: GI 50 -molar concentration of the compound that inhibits 50 % net cell growth; TGI -molar concentration of the compound leading to the total inhibition; and LC 50 -molar concentration of the compound leading to 50 % net cell death. Furthermore, a mean graph midpoints (MG_MID) were calculated 
COMPARE analysis
The obtained results of the tested compounds' antitumor activity led us to establishing a possible mode of their action. For this purpose COMPARE analysis was performed. NCI's COMPARE algorithm [37, 38] allows establishing possible biochemical mechanisms of action of the novel compounds on the basis of their in vitro activity profiles when comparing with those of standard agents. We performed COMPARE computations for the compounds IIa, IIc, IId, IIe, IIId, IIIg, IIIn, and IIIu against the NCI "Standard Agents" database at the GI 50 level (Table 3) .
Unfortunately, the calculated Pearson correlation coefficients (PCC) did not indicate cytotoxicity mechanisms of the tested compounds with high probability. The highest correlation at the GI 50 level was observed for the compound IId (PCC = 0.661) with alkylating agent fluorodopan. Interestingly, other 4-azolidinone derivatives also have significant value of correlation coefficients to the abovementioned substance [26, [39] [40] . Pearson correlation coefficients exceeding 0.6 were also calculated for the IIId (PCC = 0.631) with hydroquinone ansamycin antibiotic macbecin II, and for IIe (PCC = 0.603) with hydroxyurea which is the ribonucleotide reductase inhibitor and belongs to the class of antimetabolites. Probably, the PCC < 0.5 for the hit-compound IIIu indicates other molecular mechanisms underlying its anticancer effect.
Antitrypanosomal activity
Antitrypanosomal activity of a series of 9-aryl(heteryl)-3,7-dithia-5-azatetracyclo[9.2.1.0 2,10 .0 4, 8 ]tetradecen-4(8)-ones and N-substituted analogues was evaluated in the in vitro assay against Trypanosoma brucei brucei. All compounds were first tested at a range of concentrations. IC 50 values were further derived from the dose-response curves.
Most of the tested compounds showed mode ra te trypanocidal activity at micromolar range of concentrations. Though, some substituents in the 9 th position of the main scaffold increased the activity, e.g. ether moiety with the nitrophenyl fragment in IIk (IC 50 = Comparing anticancer profile of the tested compounds, it is worth to mention that IIg selectively inhibited growth of the Leukemia cell lines (log GI 50 = -5.16, -5.59) as well as its N-substituted derivative IIIg; and both have shown trypanocidal effects.
Conclusions
A series of novel thiopyranothiazole derivatives were synthesized and their anticancer activity was investigated. Being moderately active towards approximately 60 tumor cell lines, all tested compounds showed rather good growth inhibition against Leukemia cell lines. Chemical structures of the identified hit-com- 
